Effects of antenatal corticosteroids given prior to 26 weeks' gestation: a systematic review of randomized controlled trials
Date
2011
Authors
Onland, W.
de Laat, M.
Mol, B.
Offringa, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
American Journal of Perinatology: neonatal and maternal-fetal medicine, 2011; 28(1):33-43
Statement of Responsibility
Wes Onland, Monique W. de Laat, Ben Willem Mol, Martin Offringa
Conference Name
Abstract
Although it is generally accepted that antenatal corticosteroids reduce neonatal complications after preterm labor, it is unclear at what gestational age this effect starts to occur. We conducted a systematic review of the literature to determine the effects of antenatal corticosteroids given to women at risk of preterm birth <26 weeks' gestation. Two reviewers independently searched electronic databases and the Cochrane Library for randomized controlled trials including women at imminent birth at a gestational age <26 weeks. Nine randomized trials were included. Meta-analyses and meta-regression of trials including participants with a lower gestational age revealed no significant reduction of neonatal mortality and morbidity in the corticosteroid group as compared with nonintervention, in contrast to clear evidence of beneficial effects in trials including women given corticosteroids at a later gestational age. A gestational age-dependent effect of antenatal corticosteroids on neonatal outcomes with lesser treatment benefits in patients <26 weeks' gestational age appears to exist. There is no evidence from randomized controlled trials to support or refute the recommendation of administrating antenatal corticosteroids to women at risk of preterm birth <26 weeks' gestation.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
© Thieme Medical Publishers